D27.505.696.277.950.040

2 trials

Sponsors

Universidade Federal de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USP

Conditions

Schizophrenia

Phase 3

Use of sodium nitroprusside and its effect on negative symptoms in treatment-resistant schizophrenia

Active, not recruitingRBR-2zhgjw

Universidade Federal de São PauloSchizophrenia

Start: 2018-05-20Updated: 2025-10-27

Unknown Phase

Effects of adjunctive Mononitrate, an angin medication, in patients with a Schizophrenia diagnosis.

Active, not recruitingRBR-8kyq7g

Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto - USPSchizophrenia

Start: 2015-09-15Updated: 2025-10-27